Rakheja D - Search Results

1

Serum D-2-hydroxyglutarate and the ratio of D-2HG/L-2HG predict IDH mutation in acute myeloid leukemia.

Zhang C, Chu A, Boriack R, Collins R, Xu J, Oliver D, Zheng R, Rakheja D, Chen W. Zhang C, et al. Among authors: rakheja d. EJHaem. 2023 Jun 19;4(3):723-727. doi: 10.1002/jha2.723. eCollection 2023 Aug. EJHaem. 2023. PMID: 37601838 Free PMC article.

2

Precholesterol sterols accumulate in lipid rafts of patients with Smith-Lemli-Opitz syndrome and X-linked dominant chondrodysplasia punctata.

Rakheja D, Boriack RL. Rakheja D, et al. Pediatr Dev Pathol. 2008 Mar-Apr;11(2):128-32. doi: 10.2350/06-10-0179.1. Epub 2007 Mar 22. Pediatr Dev Pathol. 2008. PMID: 17378665

3

A severely affected female infant with x-linked dominant chondrodysplasia punctata: a case report and a brief review of the literature.

Rakheja D, Read CP, Hull D, Boriack RL, Timmons CF. Rakheja D, et al. Pediatr Dev Pathol. 2007 Mar-Apr;10(2):142-8. doi: 10.2350/06-06-0111.1. Pediatr Dev Pathol. 2007. PMID: 17378690 Review.

4

Wilms tumor in a child with L-2-hydroxyglutaric aciduria.

Rogers RE, Deberardinis RJ, Klesse LJ, Boriack RL, Margraf LR, Rakheja D. Rogers RE, et al. Among authors: rakheja d. Pediatr Dev Pathol. 2010 Sep-Oct;13(5):408-11. doi: 10.2350/09-12-0768-CR.1. Epub 2010 Jan 11. Pediatr Dev Pathol. 2010. PMID: 20064066

5

Papillary thyroid carcinoma shows elevated levels of 2-hydroxyglutarate.

Rakheja D, Boriack RL, Mitui M, Khokhar S, Holt SA, Kapur P. Rakheja D, et al. Tumour Biol. 2011 Apr;32(2):325-33. doi: 10.1007/s13277-010-0125-6. Epub 2010 Nov 16. Tumour Biol. 2011. PMID: 21080253

6

Isocitrate dehydrogenase 1/2 mutational analyses and 2-hydroxyglutarate measurements in Wilms tumors.

Rakheja D, Mitui M, Boriack RL, DeBerardinis RJ. Rakheja D, et al. Pediatr Blood Cancer. 2011 Mar;56(3):379-83. doi: 10.1002/pbc.22697. Epub 2010 Nov 22. Pediatr Blood Cancer. 2011. PMID: 21225914

7

High incidence of IDH mutations in acute myeloid leukaemia with cuplike nuclei.

Rakheja D, Konoplev S, Su M, Wheeler D, Muzny DM, Ruvolo VR, Collins R, Karandikar NJ, Andreeff M, Medeiros LJ, Chen W. Rakheja D, et al. Br J Haematol. 2011 Oct;155(1):125-8. doi: 10.1111/j.1365-2141.2011.08646.x. Epub 2011 Apr 12. Br J Haematol. 2011. PMID: 21480859 Free article. No abstract available.

8

IDH mutations in acute myeloid leukemia.

Rakheja D, Konoplev S, Medeiros LJ, Chen W. Rakheja D, et al. Hum Pathol. 2012 Oct;43(10):1541-51. doi: 10.1016/j.humpath.2012.05.003. Epub 2012 Aug 20. Hum Pathol. 2012. PMID: 22917530 Review.

9

The emerging role of d-2-hydroxyglutarate as an oncometabolite in hematolymphoid and central nervous system neoplasms.

Rakheja D, Medeiros LJ, Bevan S, Chen W. Rakheja D, et al. Front Oncol. 2013 Jul 2;3:169. doi: 10.3389/fonc.2013.00169. eCollection 2013. Front Oncol. 2013. PMID: 23847760 Free PMC article.

10

Oxidation of alpha-ketoglutarate is required for reductive carboxylation in cancer cells with mitochondrial defects.

Mullen AR, Hu Z, Shi X, Jiang L, Boroughs LK, Kovacs Z, Boriack R, Rakheja D, Sullivan LB, Linehan WM, Chandel NS, DeBerardinis RJ. Mullen AR, et al. Among authors: rakheja d. Cell Rep. 2014 Jun 12;7(5):1679-1690. doi: 10.1016/j.celrep.2014.04.037. Epub 2014 May 22. Cell Rep. 2014. PMID: 24857658 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

195 results

Search Page